Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 217-221, February 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gericke, D.
Right arrow Articles by Engelbart, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gericke, D.
Right arrow Articles by Engelbart, K.

Oncolysis by Clostridia. II. Experiments on a Tumor Spectrum With a Variety of Clostridia in Combination with Heavy Metal

Dietmar Gericke and Klaus Engelbart

( Farbwerke Hoechst, A.G., Frankfurt/M, West Germany)

The oncolytic effects of intravenously injected spores of Cl. butyricum (M-55) have been tested in a series of mouse and rat tumors. The results depended on the strain of tumor used, the age and thereby the size of the tumor, and the species of animal. Since even in the most favorable circumstances the oncolysis is rarely complete, it was attempted to improve the results by the simultaneous application of a series of metabolic products of clostridia and of tumors. The results were essentially negative.

It was observed that porphyrins present in the tumor or formed during oncolysis had a deleterious effect on the growth of clostridia. If the activity of porphyrins was blocked by the parenteral or local application of heavy metals, particularly the proper iron compounds, a faster and more extensive lysis could be obtained. This was true not only for tumors which had only a moderate sensitivity to the clostridia but also for smaller tumors of sensitive strains. Oncolysis by a series of nonpathogenic strains of clostridia was tested on three different mouse tumors, and in each instance the effect could be enhanced by the simultaneous parenteral treatment with an iron dextran complex. These observations open a way for improvement of results of spore therapy that so far were not sufficiently satisfying.

Received 6/16/63.


This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Zhao, M. Yang, H. Ma, X. Li, X. Tan, S. Li, Z. Yang, and R. M. Hoffman
Targeted therapy with a salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.
Cancer Res., August 1, 2006; 66(15): 7647 - 7652.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Zhao, M. Yang, X.-M. Li, P. Jiang, E. Baranov, S. Li, M. Xu, S. Penman, and R. M. Hoffman
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium
PNAS, January 18, 2005; 102(3): 755 - 760.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.